EyeWorld spoke to Elizabeth Yeu, MD, who stepped into her role as ASCRS president at the 2023 Annual Meeting, about her involvement with ASCRS and what she’s looking forward to in leading the Society for the next year.

When a patient is scheduled for LASIK, they have high expectations for that postop day 1 “wow” factor that LASIK provides, said Ella Faktorovich, MD. However, in the years following the onset of the COVID-19 pandemic, Dr. Faktorovich noticed increased frequency of epithelial loosening during LASIK flap lift.

MIGS procedures have become a mainstay in the treatment of mild to moderate glaucoma, but what pressures can physicians realistically expect with these? Three surgeons spoke about this, as well as how MIGS can fit into the overall glaucoma management process and what to do if MIGS procedures don’t achieve the desired IOP.

The Casey Eye Institute ophthalmology residents review this article from the December 2022 issue of the Journal of Cataract & Refractive Surgery.

➤ Positive topline results in Phase 3 clinical trial for allergic conjunctivitis treatment ➤ Phase 1b topline data on investigational dry eye drop ➤ First patients dosed in Phase 1b/2 trial for Wnt agonist antibody ➤ Study: U.S. prevalence of diabetic retinopathy ➤ ASCRS news and events